Quinn Opportunity Partners’s Filana Therapeutics FLNA Stock Holding History

Quinn Opportunity Partners’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,000	Closed	-$372K	–	259
2021 Q3	$372K	Buy	6,000 +3,000	+100%	+$250K	0.02%	206
2021 Q2	$256K	Sell	3,000 -10,000	-77%	-$536K	0.02%	213
2021 Q1	$584K	Sell	13,000 -101,000	-89%	-$3.97M	0.04%	184
2020 Q4	$777K	Buy	114,000 +33,000	+41%	+$295K	0.07%	147
2020 Q3	$932K	Buy	+81,000	New	+$365K	0.1%	113
2020 Q2	–	Sell	-35,687	Closed	-$147K	–	199
2020 Q1	$147K	Buy	+35,687	New	+$236K	0.02%	152

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Quinn Opportunity Partners's FLNA Position: Q4 2021 in Review

Quinn Opportunity Partners sold out of Filana Therapeutics (FLNA) in Q4 2021, closing a stake of 6,000 shares — an estimated $372K sold.

Quinn Opportunity Partners first reported a position in FLNA in Q1 2020 and held it in 6 quarters. The position peaked at $932K in Q3 2020. 171 funds tracked by Wall St. Rank hold FLNA as of Q4 2021.

Quinn Opportunity Partners reported no remaining Filana Therapeutics position as of Q4 2021 after selling out during the quarter.
Quinn Opportunity Partners sold 6,000 Filana Therapeutics shares in Q4 2021, an estimated $372K.
Quinn Opportunity Partners first reported a position in Filana Therapeutics in Q1 2020 and held it in 6 quarters.
Quinn Opportunity Partners's Filana Therapeutics position peaked at $932K in Q3 2020.
171 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2021.

Based on Quinn Opportunity Partners's 13F filing for Q4 2021, filed 14 Feb 2022.